BCAB Chart
- 52-Week Range: $2.13 - $51.00
- Market Capitalization: $82.68M
- Short Percentage: 0%
- Target Price: $31.00
- Shares Outstanding: 35.92M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
BCAB released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- BioAtla, Inc. (BCAB) CEO Jay Short on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha | May 7th
- BioAtla Announces Third Quarter 2021 Financial Results And Provides Clinical And Business UpdatePRNewsWire | November 15th
- BioAtla Announces Second Quarter 2021 Financial Results And Provides Clinical UpdatePRNewsWire | August 13th
Company Info
Website: https://www.bioatla.com
Address: 11085 Torreyana Road, San Diego, CA, United States, 92121
Sector: Healthcare
Industry: Biotechnology
Full time employees: 56
Address: 11085 Torreyana Road, San Diego, CA, United States, 92121
Sector: Healthcare
Industry: Biotechnology
Full time employees: 56
$BCAB bears haha
$BCAB Shorts are calling in all the favors
$BCAB has just been halted from trading due to volatility.
$BCAB choo choo
$BCAB how low can she go
$BCAB Overpower the algos!
$BCAB I gave in! Bought more 100 shares
$BCAB money comes and goes but your story stays with you the rest of your life. Apes for life ??
$BCAB Sleep well my bulls
sleep well
$BCAB The squeeze is coming